JNJ-86051823

N/A

Report date: 2025/09/02 20:00:09

Base Information

Drug NameJNJ-86051823
Drug Alias NameAd26.RSV-B.preF2RSV preF-based VaccineJNJ-86051823
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Vaccines & Prevention Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Vaccines & Prevention Bv
Active IndicationsN/A
Inactive IndicationsLower Respiratory Tract InfectionsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A